Overview

Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications

Status:
Terminated

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

We aim to investiagte whether very low dose self management of oral anticoagulation is superior to low dose oral anticoagulation in order to prevent bleeding events in patients undergoing mechanuical heart valve replacement.

Phase:

Phase 4

Details

Lead Sponsor:

Heart and Diabetes Center North-Rhine Westfalia

Collaborators:

Klinikum Ludwigshafen
University of Kiel

Treatments:

Phenprocoumon